![Immunicum updates sa](/news-release/logo/240414/0/240414.jpg?lastModified=12%2F09%2F2016%2022%3A55%3A20&size=2)
Immunicum updates safety and survival data in phase I/II liver cancer study with INTUVAX
August 24, 2015 06:50 ET
|
Immunicum AB
Gothenburg, Sweden, 2015-08-24 12:50 CEST (GLOBE NEWSWIRE) --
Immunicum AB (publ) today released an updated report on safety and survival data from the ongoing phase I/II study with INTUVAX for...
![Magnus Persson propo](/news-release/logo/240414/0/240414.jpg?lastModified=12%2F09%2F2016%2022%3A55%3A20&size=2)
Magnus Persson proposed new Board member of Immunicum
August 13, 2015 09:15 ET
|
Immunicum AB
Gothenburg, Sweden, 2015-08-13 15:15 CEST (GLOBE NEWSWIRE) --
The Nomination Committee of Immunicum AB (publ) proposes that Magnus Persson be elected as a new member of the Board at the Annual...
![Magnus Persson föres](/news-release/logo/240414/0/240414.jpg?lastModified=12%2F09%2F2016%2022%3A55%3A20&size=2)
Magnus Persson föreslås till ny styrelseledamot i Immunicum
August 13, 2015 09:15 ET
|
Immunicum AB
Göteborg, 2015-08-13 15:15 CEST (GLOBE NEWSWIRE) --
Valberedningen i Immunicum AB (publ) föreslår att Magnus Persson väljs in som ny ordinarie ledamot vid årsstämman (3 dec 2015).
Dr Magnus...
![Immunicum strengthen](/news-release/logo/240414/0/240414.jpg?lastModified=12%2F09%2F2016%2022%3A55%3A20&size=2)
Immunicum strengthens the clinical organization
August 05, 2015 03:00 ET
|
Immunicum AB
Gothenburg, Sweden, 2015-08-05 09:00 CEST (GLOBE NEWSWIRE) --
Immunicum AB (publ) strengthens its organization with the recruitment of Linda Barkemo as Director Clinical Operations.
Linda Barkemo...
![Immunicum förstärker](/news-release/logo/240414/0/240414.jpg?lastModified=12%2F09%2F2016%2022%3A55%3A20&size=2)
Immunicum förstärker den kliniska organisationen
August 05, 2015 03:00 ET
|
Immunicum AB
Göteborg, 2015-08-05 09:00 CEST (GLOBE NEWSWIRE) --
Immunicum AB (publ) förstärker organisationen med rekryteringen av Linda Barkemo som Director Clinical Operations.
Linda Barkemo har mer än 10...
![Immunicum presents c](/news-release/logo/240414/0/240414.jpg?lastModified=12%2F09%2F2016%2022%3A55%3A20&size=2)
Immunicum presents continued improvement in phase I/II survival data for INTUVAX-treated renal cancer patients
August 04, 2015 03:00 ET
|
Immunicum AB
Gothenburg, Sweden, 2015-08-04 09:00 CEST (GLOBE NEWSWIRE) --
Immunicum AB (publ) today announced continued improvement in survival data from the follow-up phase of a clinical phase I/II trial in...
![Immunicum presentera](/news-release/logo/240414/0/240414.jpg?lastModified=12%2F09%2F2016%2022%3A55%3A20&size=2)
Immunicum presenterar fortsatt förbättrade fas I/II överlevnadsdata för INTUVAX-behandlade njurcancerpatienter
August 04, 2015 03:00 ET
|
Immunicum AB
Göteborg, 2015-08-04 09:00 CEST (GLOBE NEWSWIRE) --
Immunicum AB (publ) offentliggjorde idag fortsatt förbättrade data från uppföljningsfasen av en fas I/II-prövning på patienter med metastaserande...
![Immunicum anställer](/news-release/logo/240414/0/240414.jpg?lastModified=12%2F09%2F2016%2022%3A55%3A20&size=2)
Immunicum anställer Lise-Lotte Hallbäck som ny CFO
July 13, 2015 02:30 ET
|
Immunicum AB
Göteborg, 2015-07-13 08:30 CEST (GLOBE NEWSWIRE) --
Immunicum AB (publ) förstärker organisationen med rekryteringen av Lise-Lotte Hallbäck som CFO.
Lise-Lotte Hallbäck tillträder tjänsten den 1...
![Immunicum hires Lise](/news-release/logo/240414/0/240414.jpg?lastModified=12%2F09%2F2016%2022%3A55%3A20&size=2)
Immunicum hires Lise-Lotte Hallbäck as new CFO
July 13, 2015 02:30 ET
|
Immunicum AB
Gothenburg, Sweden, 2015-07-13 08:30 CEST (GLOBE NEWSWIRE) --
Immunicum AB (publ) strengthens its organization with the recruitment of Lise-Lotte Hallbäck as CFO.
Lise-Lotte Hallbäck will assume...
![Immunicum: Delårsrap](/news-release/logo/240414/0/240414.jpg?lastModified=12%2F09%2F2016%2022%3A55%3A20&size=2)
Immunicum: Delårsrapport juli 2014 – mars 2015
May 21, 2015 02:30 ET
|
Immunicum AB
Göteborg, 2015-05-21 08:30 CEST (GLOBE NEWSWIRE) --
Juli 2014 – mars 2015 jämfört med samma period 2013/2014
Resultat
Resultatet för tredje kvartalet, 1 januari-31 mars 2015, uppgick till -10...